๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Is it really possible to cure hairy cell leukemia patients only with frontline therapy?

โœ Scribed by Zinzani, Pier Luigi; Stefoni, Vittorio; Broccoli, Alessandro; Pellegrini, Cinzia; Gandolfi, Letizia; Casadei, Beatrice; Maglie, Roberto; Pileri, Stefano; Argnani, Lisa

Book ID
125344176
Publisher
Springer
Year
2014
Tongue
English
Weight
172 KB
Volume
93
Category
Article
ISSN
0939-5555

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Is it possible to discontinue imatinib m
Is it possible to discontinue imatinib mesylate therapy in Chronic Myeloid Leukemia patients with undetectable BCR/ABL? A case report and a review of the literature
โœ Salvatore Guastafierro; Umberto Falcone; Maria Celentano; Milena Coppola; Maria ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 111 KB

Imatinib mesylate (IM) therapy leads to a complete cytogenetic response (CCyR) in 75-90% of Chronic Myeloid Leukemia (CML) patients in chronic phase, but only a small percentage of patients achieve complete molecular response (CMR). Very little is known about IM discontinuation. We report the case o